The global digital diabetes management market was valued at USD 13.4 billion in 2024 and is projected to grow significantly, reaching USD 21.9 billion by 2030. This expansion represents a compound annual growth rate (CAGR) of 8.7% between 2025 and 2030. The robust growth trajectory of the market is primarily driven by two key factors: the rising prevalence of diabetes worldwide and the continuous technological advancements that are transforming diabetes care into a more connected, data-driven, and patient-centric approach.

According to the International Diabetes Federation (IDF), around 536 million adults were living with diabetes in 2021, and this number is forecasted to surge to 783 million by 2045. This sharp rise highlights the increasing global healthcare burden, necessitating advanced and scalable solutions for monitoring and managing the disease. In this context, digital diabetes management technologies ranging from apps and wearables to smart insulin devices and AI-powered platforms are becoming indispensable in improving patient outcomes, reducing complications, and optimizing treatment plans.

The rapid integration of digital health technologies into diabetes care has already transformed the ecosystem. For instance, the number of smartphone applications dedicated to diabetes management has grown substantially in recent years. Today, hundreds of apps are available across online platforms, enabling patients to easily track blood glucose levels, insulin usage, diet, and physical activity. These solutions not only empower patients with self-management tools but also provide physicians with real-time data for more personalized treatment decisions.

Key Market Trends & Insights:

  • North America held the largest market share of 38.2% in 2024, supported by high diabetes prevalence, widespread adoption of advanced healthcare technologies, and favorable reimbursement policies for digital health solutions.
  • Asia Pacific is projected to register the fastest CAGR of 10.2% during the forecast period. Factors driving this growth include a rapidly growing diabetic population, increasing healthcare investments, rising smartphone penetration, and strong government initiatives to promote digital health adoption.
  • Continuous glucose monitoring (CGM) systems dominated the market in 2024, capturing a 40.4% revenue share, owing to their ability to provide real-time glucose readings and improve disease management by reducing the need for frequent fingerstick tests. Smart insulin pens are expected to expand at the fastest CAGR of 11.8% during the forecast period. Their popularity is rising due to features like dose tracking, reminders, and smartphone connectivity, which improve treatment adherence and accuracy.
  • Wearable devices held the largest share of the market in 2024 and are projected to continue growing at the fastest CAGR of 8.9%. These include smartwatches, fitness trackers, and connected biosensors that integrate with mobile apps to deliver seamless glucose and lifestyle monitoring.
  • Hospitals accounted for the largest market share of 41.5% in 2024, as they remain primary centers for deploying advanced diagnostic and monitoring solutions. Hospitals also play a central role in integrating digital diabetes tools with electronic health records (EHRs) for better patient management. The home settings segment is forecasted to grow at the fastest rate of 5.2% over the period. The increasing availability of user-friendly devices, combined with the shift towards remote patient monitoring and telehealth, is making home-based diabetes care more feasible and accessible.

Order a free sample PDF of the Digital Diabetes Management Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

  • 2024 Market Size: USD 13.4 Billion
  • 2030 Projected Market Size: USD 21.9 Billion
  • CAGR (2025-2030): 8.7%
  • North America: Largest market in 2024
  • Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

The digital diabetes management industry is highly competitive, with major players and emerging companies focusing on innovation and strategic growth initiatives to strengthen their positions. The leading strategies include:

  • Product innovation and launches: Introducing advanced digital health solutions that integrate features such as AI-driven analytics, remote connectivity, and real-time monitoring.
  • Strategic partnerships and collaborations: Collaborating with healthcare providers, insurance companies, and technology firms to expand solution accessibility and interoperability.
  • Regional expansion: Entering new geographies to cater to the rapidly growing diabetic population in emerging markets.
  • Mergers and acquisitions: Consolidating expertise, expanding product portfolios, and scaling distribution networks.
  • Integration of AI and machine learning: Leveraging advanced analytics for predictive modeling, personalized treatment recommendations, and improved clinical decision-making in diabetes care.

These strategies are helping companies not only to expand their global reach but also to deliver more effective, patient-centered digital solutions, thereby transforming the way diabetes is managed worldwide.

Key Players

  • Abbott
  • Medtronic
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • Sanofi
  • Dexcom, Inc.
  • LifeScan, Inc.
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global digital diabetes management market is experiencing steady and sustained growth, fueled by the rising global diabetes burden and the continuous wave of technological innovations. North America leads in adoption, but Asia Pacific is poised to become the fastest-growing region. Product innovation in CGMs, smart insulin pens, and wearables is reshaping patient care, while the shift towards home-based digital solutions is making diabetes management more accessible and convenient. With increasing investments in AI-driven healthcare and connected devices, the industry is set to play a pivotal role in redefining diabetes care over the coming decade.